Irrespective of what u might think of the management etc ref CHM ..and no point discussion further ....
The progress being made with the IP is exciting .
Were the IP to be sold off ...its likely to be at a price 4-5 times the current market cap of the entity . ...is my guess . ( possibly a lot higher )
The Team , the IP , the ground floor knowledge would be an incredible bolt onto a large pharma , looking to get a leg up in the oncology space .
Irrespective of what u might think of the management etc ref CHM...
Add to My Watchlist
What is My Watchlist?
